Funds holding Beam Therapeutics Inc
ISIN US07373V1052 · United States
- Fund holders
- 230
- Of which ETFs
- 54 176 other funds
- Value held
- 1.1B $ 94.4K € · 7.6M SEK
- Share of capital
- 40.7 % of 103.3M shares on Jul 28, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,208 | 28.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 1,202 | 28.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,078 | 32.7K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,068 | 25.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 1,060 | 25.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| NVIT GS Small Cap Equity Insights Fund Nationwide Variable Insurance Trust | 1,018 | 24.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 1,004 | 28.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 883 | 26.8K $ | 0.17 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 795 | 22.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 758 | 18.1K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 709 | 20.2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 488 | 14.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 475 | 11.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 464 | 11.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 449 | 10.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 449 | 10.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 320 | 7.6K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 312 | 9.5K $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 242 | 5.8K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 231 | 5.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 218 | 5.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 174 | 5.3K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 131 | 3.1K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 98 | 2.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 91 | 2.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 91 | 2.2K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 50 | 1.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 32 | 910.7 $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 25 | 595.8 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 94.4K € | 0.71 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ARK Genomic Revolution ETF ARK ETF Trust | 5.43 % | as of Apr 30, 2026 ↗ |
| Jacob Small Cap Growth Fund Jacob Funds Inc. | 3.90 % | as of Feb 28, 2026 ↗ |
| American Beacon ARK Transformational Innovation Fund AMERICAN BEACON FUNDS | 3.40 % | as of Mar 31, 2026 ↗ |
| ARK Innovation ETF ARK ETF Trust | 3.06 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 2.21 % | as of Feb 28, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 1.82 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 1.79 % | as of Mar 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 1.15 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 1.09 % | as of Apr 30, 2026 ↗ |
| YORKTOWN SMALL CAP FUND American Pension Investors Trust | 1.08 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 228 | +16 | 41,978,058 | -0.8 % |
| 2026Q1 | 212 | -2 | 42,313,909 | +8.2 % |
| 2025Q4 | 214 | -2 | 39,120,026 | -6.1 % |
| 2025Q3 | 216 | -5 | 41,667,706 | +23.1 % |
| 2025Q2 | 221 | +11 | 33,836,661 | +25.4 % |
| 2025Q1 | 210 | -5 | 26,975,974 | -4.2 % |
| 2024Q4 | 215 | -8 | 28,149,115 | -5.4 % |
| 2024Q3 | 223 | -6 | 29,764,517 | +3.2 % |
| 2024Q2 | 229 | +29 | 28,849,635 | -3.4 % |
| 2024Q1 | 200 | -8 | 29,879,968 | +3.1 % |
| 2023Q4 | 208 | 28,985,082 |
Institutional managers
243 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 12,452,199 | 296.7M $ | as of Mar 31, 2026 |
| ARK Investment Management LLC | 12,133,433 | 289.1M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 10,134,696 | 241.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,487,569 | 202.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,699,265 | 135.8M $ | as of Mar 31, 2026 |
| ARCH Venture Management, LLC | 4,540,132 | 108.2M $ | as of Mar 31, 2026 |
| Amova Asset Management Americas, Inc. | 3,825,585 | 91.2M $ | as of Mar 31, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 3,825,585 | 91.2M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 3,682,185 | 87.7M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,713,230 | 64.7K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,418,592 | 57.6M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 2,154,575 | 51.3M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,653,714 | 39.4M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,446,375 | 34.5M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 1,350,000 | 32.2M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 1,237,659 | 29.5M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,210,853 | 28.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 1,084,768 | 25.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,005,743 | 24M $ | as of Mar 31, 2026 |
| UBS Group AG | 826,061 | 19.7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 825,580 | 19.7M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 820,765 | 19.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 808,436 | 19.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 700,647 | 16.7M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 648,264 | 15.4M $ | as of Mar 31, 2026 |
Declared shareholders of Beam Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.02 % | 5,122,475 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Beam Therapeutics Inc". https://titelia.com/en/stocks/beam-therapeutics-inc-US07373V1052